Covered recipient · General Payments record
TAYLOR J SLINGSBY
Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist
General Payments · PY2018–2024
$3,536.40
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $406.77 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $178.29 | 4 |
| Astellas Pharma US Inc | $154.34 | 3 |
| Genentech USA, Inc. | $34.27 | 2 |
| Tarsus Pharmaceuticals, Inc. | $22.63 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.03 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119193 | CMS |
| ABBVIE INC. | $8.16 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119195 | CMS |
| ABBVIE INC. | $125.00 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119197 | CMS |
| ABBVIE INC. | $22.10 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119199 | CMS |
| Astellas Pharma US Inc | $115.54 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139414837 | CMS |
| Astellas Pharma US Inc | $25.66 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139358467 | CMS |
| Astellas Pharma US Inc | $13.14 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139367657 | CMS |
| Genentech USA, Inc. | $15.66 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133122563 | CMS |
| Genentech USA, Inc. | $18.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133122568 | CMS |
| Regeneron Healthcare Solutions, Inc. | $17.24 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114178782 | CMS |
| Tarsus Pharmaceuticals, Inc. | $22.63 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139133100 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.